Search research articles
Contact Us
Filters
Showing results (81-90 of 301) with videos related to
Page
of 31
Sort By:
Brain Research
|
November 14, 1983
Regional somatostatin distribution in the rat striatum
M F Beal, V B Domesick, J B Martin
Neuroscience Letters
|
May 27, 1991
2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity
S F Finn, K J Swartz, M F Beal
Brain Research
|
August 11, 1987
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease
D W Ellison, M F Beal, J B Martin
Brain Research
|
November 12, 1986
Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes
M F Beal, M F Mazurek, J B Martin
Experimental Neurology
|
August 1, 1994
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum
D M Frim, U Wüllner, M F Beal, et al.
Neurotoxicity Research
|
June 22, 2006
Neuroprotective and neurorestorative strategies for neuronal injury
M F Beal, T Palomo, R M Kostrzewa, et al.
Brain Research
|
March 30, 1999
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase
R J Ferrante, P Hantraye, E Brouillet, et al.
Neuroreport
|
November 17, 2001
Lipoic acid improves survival in transgenic mouse models of Huntington's disease
O A Andreassen, R J Ferrante, A Dedeoglu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 1, 1990
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors
K J Swartz, M J During, A Freese, et al.
Neuroreport
|
November 4, 1996
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease
W R Galpern, R T Matthews, M F Beal, et al.
Page
of 31
Search research articles
Search
Showing results (81-90 of 301) with videos related to
Sort By:
Page
of 31
Brain Research
|
November 14, 1983
Regional somatostatin distribution in the rat striatum
M F Beal, V B Domesick, J B Martin
Neuroscience Letters
|
May 27, 1991
2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity
S F Finn, K J Swartz, M F Beal
Brain Research
|
August 11, 1987
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease
D W Ellison, M F Beal, J B Martin
Brain Research
|
November 12, 1986
Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes
M F Beal, M F Mazurek, J B Martin
Experimental Neurology
|
August 1, 1994
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum
D M Frim, U Wüllner, M F Beal, et al.
Neurotoxicity Research
|
June 22, 2006
Neuroprotective and neurorestorative strategies for neuronal injury
M F Beal, T Palomo, R M Kostrzewa, et al.
Brain Research
|
March 30, 1999
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase
R J Ferrante, P Hantraye, E Brouillet, et al.
Neuroreport
|
November 17, 2001
Lipoic acid improves survival in transgenic mouse models of Huntington's disease
O A Andreassen, R J Ferrante, A Dedeoglu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 1, 1990
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors
K J Swartz, M J During, A Freese, et al.
Neuroreport
|
November 4, 1996
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease
W R Galpern, R T Matthews, M F Beal, et al.
Page
of 31